Month: June 2020

Company announcement – No. 33 / 2020Zealand Pharma strengthens executive team with new U.S. leadershipCopenhagen, June 15, 2020 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company changing lives with innovative peptide-based medicines, today announced the appointment of Frank Sanders as President of Zealand Pharma U.S. Frank will join Zealand on July 6, 2020.“I am pleased to welcome Frank Sanders to Zealand Pharma, and am confident that he will provide strong and experienced leadership for our U.S. organization,” said Emmanuel Dulac, President and Chief Executive Officer at Zealand Pharma. “Frank has more than 25 years of experience within commercial operations. He is well equipped to lead Zealand’s commercial operations to focus on growing existing sales of V-Go and to successfully launch four potential products...

Zaandam, the Netherlands, June 15, 2020 – Ahold Delhaize today announces the publication of its inaugural Human Rights Report. The report is an important milestone to show what steps Ahold Delhaize and its great local brands are taking to safeguard human rights, both within the organization and across the supply chain, as well as increase transparency on the highest priority human rights issues for Ahold Delhaize and its brands.The report is based on the UN Guiding Principles Reporting Framework and is the result of a global human rights due diligence process that began in 2018. This due diligence process was designed to increase engagement on human rights – both internally and externally – and to assess current human rights management policies, processes and governance. The Human Rights Report outlines the outcome of this due diligence...

15 June 2020 Alliance Trust PLCTRANSACTION IN OWN SHARES The Board of Alliance Trust PLC (“the Company”) announces that on 11 June 2020 the Company purchased for cancellation 60,000 ordinary shares of 2.5p each at a price of 756.2161p per share. Therefore, the total number of voting rights in the Company is now 327,298,733.   The above figure (327,298,733) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure and Transparency Rules. Enquiries: Alliance Trust PLC Telephone: 01382 938320

Schiphol – 15 June 2020.  As the operational situation has developed considerably since its first quarter 2020 press release of 5 May 2020, GrandVision N.V. (EURONEXT: GVNV) publishes an update on the impact of COVID-19 on its business.Stephan Borchert, CEO of GrandVision said: “As governments started to ease measures aimed at containing the spread of COVID-19, we have seen sales improve considerably across many of our markets. As of 30 May 2020, approximately 4,700, or 80% of our own stores returned to full operation, including in most of our markets across Europe.As reported on 5 May 2020, approximately 60% of GrandVision stores were closed in April and 40% were partially open but impacted by various degrees of sales limitations. Accordingly, GrandVision experienced in April 2020 a negative revenue impact of more than 80% compared to...

Considering the ongoing Covid-19 situation and the resulting market uncertainty, Hydro presents an operational update for its business areas for April and May, ahead of the complete second-quarter financial results on July 22, 2020.           Bauxite and Alumina Volumes in April and May have increased compared to the same period in 2019, as a result of the increased production at the Paragominas bauxite mine and the Alunorte alumina refinery in Brazil, following the lifting of the production embargo.Primary Metal Volumes in April and May have slightly increased compared to the same period in 2019, reflecting increased production at the Albras smelter in Brazil, which was partially curtailed during 2019, partly offset by decreased production at the curtailed Slovalco smelter in Slovakia.Metal MarketsVolumes in April and May for the Recycling...

På bakgrunn av den pågående Covid-19-situasjonen og den resulterende usikkerheten i markedet gir Hydro en driftsoppdatering for forretningsområdene for april og mai, i forkant av at resultatene for andre kvartal blir offentligjort 22. juli 2020.Bauksitt & Alumina Volumet for april og mai har økt sammenlignet med samme periode i 2019. Volumøkningen skyldes høyere produksjon ved bauksittgruven Paragominas og aluminaraffineriet Alunorte etter at produksjonsembargoen ble løftet.Primærmetall Volumet for april og mai har hatt en svak økning sammenlignet med samme periode 2019. Volumøkningen gjenspeiler økt produksjon ved smelteverket Albras i Brasil, der deler av anlegget var midlertidig stengt i 2019, og ble delvis utliknet av redusert produksjon ved smelteverket Slovalco i Slovakia.MetallmarkedVolumet for april og mai for resirkuleringsenheten...

Press Release15 June 2020Immunicum AB (publ) Announces Advancement to a Non-Staggered Inclusion Phase in the Phase Ib/II ILIAD Combination TrialImmunicum AB (publ; IMMU.ST) announced today that the sixth patient has completed the safety period in the ongoing Phase Ib/II ILIAD combination trial with ilixadencel, the Company’s cell-based, off-the-shelf immune primer for the treatment of solid tumors. The Dose Escalation Committee (DEC) confirmed there were no dose limiting toxicities, therefore the study can move into the non-staggered inclusion phase.The Phase Ib portion of the ILIAD trial is evaluating the safety and tolerability of Immunicum’s lead candidate, ilixadencel, in combination with the checkpoint inhibitor (CPI) Keytruda® (pembrolizumab) in 21 patients. In the staggered part of the Phase Ib portion, the initial 3 patients received...

Pressmeddelande15 juni 2020Immunicum AB (publ) meddelar övergång till fortlöpande inklusionsfas i Fas Ib/II kombinationsstudien ILIADImmunicum AB (publ; IMMU.ST) meddelade i dag att den sjätte patienten har avslutat säkerhetsperioden i den pågående Fas Ib/II kombinationsstudien ILIAD med ilixadencel, bolagets cellbaserade immunaktiverare för behandling av solida tumörer. Dosesklaleringskommittén (DEC) bekräftade att det inte fanns några dosbegränsande toxiciteter vilket innebär att studien kan övergå från en stegvis till en fortlöpande inklusionsfas.Fas Ib-delen av ILIAD-studien utvärderar säkerheten och tolerabiliteten för Immunicums ledande läkemedelskandidat, ilixadencel, i kombination med checkpointhämmaren (CPI) Keytruda® (pembrolizumab) hos 21 patienter. I den stegvisa inkluderingsdelen av fas Ib-studien erhöll de första 3 patienterna...

Oslo, Norway, 15 June 2020 – Thin Film Electronics ASA (“Thinfilm”), a developer of ultrathin, flexible, and safe energy storage solutions for wearable devices and connected sensors, today announced the attainment of a critical milestone essential to the production of solid-state lithium battery (SSLB) products in the Company’s San Jose, California manufacturing facility. The Company can confirm that it has successfully completed the deposition of critical layers of its SSLB stack on Thinfilm steel substrates and initial electrical testing has met and exceeded internal expectations. This achievement reflects substantial development progress, on schedule, supporting the Company’s strategy to deliver premium energy storage with superior volumetric energy density.Thinfilm SSLB devices are formed through the deposition of lithium-based...

DENVER, June 14, 2020 (GLOBE NEWSWIRE) — Extraction Oil & Gas, Inc. (NASDAQ: XOG) (together with its subsidiaries, “Extraction” or the “Company”) announced today that the Company has voluntarily filed for petitions for relief under chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware (the “Court”).The Company has obtained a committed $125 million debtor-in-possession financing facility (the “DIP Facility”), which contemplates $50 million in new money, up to $15 million of which will become immediately available upon Bankruptcy Court’s order, and a “roll up” of $75 million of revolving loans under the Company’s existing revolving credit agreement. The DIP Facility is underwritten by Wells Fargo Bank, National Association and the $50 million in new money is financed by certain lenders...